Price: $399.99
Access: 30 Months
Deliverables: 20 Hours of AAPA Category 1 Pharmacology Credit, High-Yield Question Bank, 1,600+ Practice Questions.
In the current clinical landscape of 2026, the complexity of pharmacotherapeutics has reached an all-time high. With the rapid introduction of novel biologics, updated guidelines for chronic disease management, and the increasing scrutiny on prescriptive authority, the answer is a resounding yes: your pharmacology CME matters more than ever. For physician assistants and nurse practitioners, maintaining a robust understanding of drug interactions, contraindications, and therapeutic windows is not just a regulatory requirement: it is a cornerstone of patient safety.
At CME Review Courses, we recognize that your time is your most valuable asset. That is why our Pharmacology Review Course is designed by PAs, for PAs. We cut through the academic fluff to deliver high-yield, clinically relevant information that you can apply at the bedside immediately. Whether you are prepping for the PANRE-LA or simply need to satisfy your state’s pharmacology requirements, our course provides an efficient, authoritative solution.
Why AAPA Category 1 Credit is the Gold Standard
For PAs, AAPA Category 1 Credit is the currency of professional standing. While Category 2 credits are useful, Category 1 credits are mandated for NCCPA certification maintenance. Specifically, our Pharmacology Review Course offers 20 hours of AAPA Category 1 Pharmacology Credit, which is critical for PAs in states with specific prescriptive authority mandates.
For Nurse Practitioners, these credits are frequently recognized by state boards and the ANCC. However, we always recommend verifying with your specific credentialing body to ensure these credits meet your local requirements. By choosing a course accredited by the AAPA, you are ensuring that the content has met rigorous educational standards.
Maximizing Your CME Budget with Gift Card Add-Ons
One of the most unique features of CME Review Courses is our ability to help you maximize your employer-provided CME allowance. We offer CME with Amazon Gift Card and CME with Apple Gift Card add-ons.
Price: $100 – $1,500 Gift Card Add-on Options
Delivery: Email within 2-3 business days
Flexibility: Use for medical equipment, textbooks, or further educational resources.
By adding a $1,500 Amazon Gift Card to your PANRE Review Course or Pharmacology Package, you are essentially pre-funding your educational needs for the rest of the cycle. You can purchase our Comprehensive PANCE Review Book or other clinical tools directly through Amazon using these funds. It is a pragmatic way to ensure none of your CME money goes to waste at the end of the fiscal year.
Clinical Vignette: Acute Management of Gout
Scenario:
Your patient is a 54-year-old male with a history of hypertension and Stage 3 Chronic Kidney Disease (CKD). He presents to the clinic with acute onset of severe pain, redness, and swelling of the first metatarsophalangeal (MTP) joint. He describes the pain as 10/10 and states it started suddenly last night. His current medications include Lisinopril and Hydrochlorothiazide. Vital signs are: HR 88, BP 142/88, Temp 98.9°F. Joint aspiration confirms the presence of negatively birefringent needle-shaped crystals.
What is the most appropriate first-line pharmacologic treatment for this patient's acute gout flare?
A. Indomethacin
B. Colchicine
C. Prednisone
D. Allopurinol
Correct Answer: C. Prednisone
Explanation:
In a patient with Stage 3 CKD, Prednisone is the safest and most appropriate first-line choice for an acute gout flare. Indomethacin and other NSAIDs are generally contraindicated in patients with significant renal impairment due to the risk of further decreasing the glomerular filtration rate (GFR). Colchicine requires significant dose adjustment in renal impairment and is often avoided in patients with a GFR below 30-50 mL/min depending on the clinical context. Allopurinol is a xanthine oxidase inhibitor used for chronic urate-lowering therapy, not for the management of an acute flare; starting it during an acute episode can actually worsen the symptoms by causing rapid shifts in serum urate levels.
The Value of Practice Questions
Every one of our courses, including the Pharmacology Review Course, includes access to a massive bank of practice questions. We believe that passive listening to lectures is insufficient for long-term retention.
Deliverables:
- 1,600+ board-style questions for the PANRE Review.
- Detailed explanations for every answer choice.
- Content mapped to the NCCPA Blueprint.
- 30 months of access to all materials.
Clinical Vignette: Hypertension Management
Scenario:
Your patient is a 42-year-old African American female with newly diagnosed Stage 1 Hypertension. Her average blood pressure over three readings is 138/92 mmHg. She has no other comorbidities, and her renal function is normal. You decide to initiate monotherapy.
Which of the following is the most appropriate initial antihypertensive agent for this patient?
A. Lisinopril
B. Losartan
C. Amlodipine
D. Metoprolol
Correct Answer: C. Amlodipine
Explanation:
According to the JNC 8 and ACC/AHA guidelines, Amlodipine (a Calcium Channel Blocker) or a thiazide-type diuretic is recommended as first-line therapy for the general African American population, including those with diabetes. Lisinopril (an ACE inhibitor) and Losartan (an ARB) are less effective as monotherapy in this demographic unless the patient has comorbid CKD or heart failure. Metoprolol is not typically used as first-line therapy for uncomplicated hypertension.
Why Choose CME Review Courses?
The content you consume should be created by people who understand the daily reality of your practice. Our courses are written by physician assistants. We know the pressure of a 15-minute appointment slot and the complexity of managing multi-morbid patients.
When you purchase our Family Medicine CME Package or our pharmacology-specific tracks, you are getting distilled expertise. You aren't just checking a box for the NCCPA; you are refining your clinical judgment.
Clinical Vignette: Diabetic Ketoacidosis (DKA)
Scenario:
Your patient is a 22-year-old female with Type 1 Diabetes Mellitus who is brought to the Emergency Department with nausea, vomiting, and abdominal pain. Her SaO2 is 98% on room air, HR is 115, and BP is 105/65. Labs reveal a blood glucose of 450 mg/dL, an arterial pH of 7.15, and positive serum ketones. You initiate aggressive fluid resuscitation with Normal Saline.
Before starting an intravenous insulin infusion, which of the following laboratory values must be confirmed?
A. Serum Sodium
B. Serum Potassium
C. Serum Bicarbonate
D. Hemoglobin A1c
Correct Answer: B. Serum Potassium
Explanation:
Serum Potassium must be at least 3.3 mEq/L before starting insulin therapy in DKA. Insulin causes potassium to shift intracellularly, which can lead to life-threatening hypokalemia if the patient's initial levels are already low. Serum Sodium is important for calculating the corrected glucose but does not dictate the start of insulin. Bicarbonate reflects the severity of the acidosis, and A1c is a measure of long-term control, neither of which are immediate prerequisites for starting the insulin drip in the acute setting.
Final Thoughts for the 2026 Cycle
As we move through 2026, the requirements for PAs and NPs will only continue to evolve. Staying ahead of the curve requires high-quality, accessible education. Our CME with Gift Card packages offer the perfect blend of professional development and financial efficiency.
Don't wait until the end of your cycle to scramble for credits. Invest in a course that offers 100 hours of AAPA Category 1 credit for your PANRE review or specialized pharmacology hours to keep your prescriptive authority secure.
Price: Starting at $399.99
Course: 30-Month Access
Support: (419) 203-8154 (8am-5pm, 7 days/week)
Visit CME Review Courses today to find the package that fits your career goals.